GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetron Holdings Ltd (NAS:GTH) » Definitions » Price-to-Owner-Earnings

Genetron Holdings (Genetron Holdings) Price-to-Owner-Earnings : (As of Jun. 08, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Genetron Holdings Price-to-Owner-Earnings?

As of today (2024-06-08), Genetron Holdings's share price is $4.02. Genetron Holdings does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Genetron Holdings's Price-to-Owner-Earnings or its related term are showing as below:


GTH's Price-to-Owner-Earnings is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 24.695
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-06-08), Genetron Holdings's share price is $4.02. Genetron Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2022 was $-3.52. Therefore, Genetron Holdings's PE Ratio for today is At Loss.

As of today (2024-06-08), Genetron Holdings's share price is $4.02. Genetron Holdings's EPS without NRI for the trailing twelve months (TTM) ended in was $-3.30. Therefore, Genetron Holdings's PE Ratio without NRI for today is At Loss.


Genetron Holdings Price-to-Owner-Earnings Historical Data

The historical data trend for Genetron Holdings's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genetron Holdings Price-to-Owner-Earnings Chart

Genetron Holdings Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Price-to-Owner-Earnings
Get a 7-Day Free Trial - - - - -

Genetron Holdings Quarterly Data
Dec17 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Dec22
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Genetron Holdings's Price-to-Owner-Earnings

For the Diagnostics & Research subindustry, Genetron Holdings's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genetron Holdings's Price-to-Owner-Earnings Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Genetron Holdings's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Genetron Holdings's Price-to-Owner-Earnings falls into.



Genetron Holdings Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Genetron Holdings's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=4.02/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genetron Holdings  (NAS:GTH) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Genetron Holdings Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Genetron Holdings's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Genetron Holdings (Genetron Holdings) Business Description

Traded in Other Exchanges
N/A
Address
No. 8 Life Science Parkway, 1-2nd Floor, Building 11, Zone 1, Changping District, Beijing, CHN, 102206
Genetron Holdings Ltd is an oncology company in China. It is specialized in cancer molecular profiling and harnesses advanced technologies in molecular biology and data science to transform cancer treatment. The company's operating segment includes Diagnosis and monitoring - provision for LDT services; Diagnosis and monitoring - sale of IVD products and Development services. It generates maximum revenue from the Diagnosis and monitoring - provision for LDT services segment.